Related Experiment Video
Updated: Jun 4, 2026

A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats
Published on: May 22, 2019
Inflammation and depression: why poststroke depression may be the norm and not the exception
Michaela C Pascoe1, Sheila G Crewther, Leeanne M Carey
1Brain Sciences Institute, Swinburne University, Melbourne, Vic, Australia.
Ischaemic stroke can lead to depression by triggering inflammation and cell death in brain regions. Understanding these immune processes, including cytokines and excitotoxicity, is key to addressing post-stroke mood disorders.
Area of Science:
- Neuroscience
- Immunology
- Psychiatry
Background:
- Ischaemic stroke frequently precedes clinical depression, impacting patient prognosis.
- Post-stroke depression (PSD) significantly affects recovery and long-term outcomes.
- Biological mechanisms linking stroke-induced brain changes to depression require further elucidation.
Purpose of the Study:
- To systematically review immunological processes driving inflammation-related cell death in mood-related brain regions post-ischaemic stroke.
- To investigate the role of specific molecular factors in the development of PSD.
- To enhance understanding of the biological underpinnings of depression following stroke.
Main Methods:
- Systematic literature review focusing on immunological pathways and cell death mechanisms.
- Analysis of studies examining inflammation, cytokines, and apoptosis in brain regions affected by ischaemic damage.
- Examination of factors such as intracellular calcium, glutamate excitotoxicity, and free radicals.
Main Results:
- Inflammation-related cell death pathways are activated in mood-related brain regions after ischaemic stroke.
- Cytokine-driven intrinsic apoptosis factors are implicated in the pathogenesis of PSD.
- Elevated intracellular calcium, glutamate excitotoxicity, and free radicals correlate with increased depression likelihood.
Conclusions:
- Immunological processes, particularly inflammation-induced cell death, are critical in the development of post-stroke depression.
- Targeting cytokine-driven apoptosis and associated molecular factors may offer therapeutic strategies for PSD.
- Further research into these mechanisms is essential for improving outcomes for stroke survivors experiencing depression.
Related Concept Videos
Depression: Overview
Ischemic Stroke ll: Pathophysiology
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Ischemic Stroke l: Introduction
Stroke: Introduction and Types
Hemorrhagic Stroke ll: Pathophysiology
